Home > Insider Trading > Filing (0000914190-12-000246)

Filing Details

Accession Number:: 0000914190-12-000246
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-04-02 16:28:14
Reporting Period:: 2012-03-30

Filing Date:: 2012-04-02
Accepted Time:: 2012-04-02 15:28:14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1133869	Nile Therapeutics Inc.	NLTX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1468482	Hsiao Lieu	C/O Nile Therapeutics, Inc. 115 Sansome Street, Suite #310 San Francisco CA 94104	Executive Vp, Clinical Dev.	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-03-30	12,500	$0.00	12,600	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant (Right to Buy)	Acquisiton	2012-03-30	9,375	$0.00	9,375	$0.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
9,375			No	4	P	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (Right to Buy)	$4.45		2018-03-10	200,000	200,000	Direct
Common Stock	Stock Option (Right to Buy)	$4.45		2018-03-10	46,623	46,623	Direct
Common Stock	Stock Option (Right to Buy)	$0.88	2009-01-16	2019-01-16	31,103	31,103	Direct
Common Stock	Stock Option (Right to Buy)	$1.14		2019-07-07	128,442	128,442	Direct
Common Stock	Stock Option (Right to Buy)	$0.30		2020-07-08	100,000	100,000	Direct
Common Stock	Stock Option (Right to Buy)	$0.78		2021-05-26	100,000	100,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2018-03-10	200,000	200,000	Direct
2018-03-10	46,623	46,623	Direct
2019-01-16	31,103	31,103	Direct
2019-07-07	128,442	128,442	Direct
2020-07-08	100,000	100,000	Direct
2021-05-26	100,000	100,000	Direct

Footnotes

The reported securities were purchased by the Reporting Person at an aggregate price of $0.40 for one share of common stock and three-fourths of a warrant to purchase one share of common stock.
Exercisable as to 50,000 shares on 3/10/09 and as to 4,167 shares each month thereafter for 36 months.
On 03/10/08, the Reporting Person was granted an option to purchase up to 100,000 shares of common stock of the Issuer. Up to 1/4 of the shares subject to the option may vest annually (or a pro rata portion thereof for a period of less than a full year) based on the achievement of certain performance milestones as determined by the Compensation Committee of the Board of Directors (the Committee") of the Issuer. On 1/19/09, the Committee determined that options for the prorated period ending 12/31/08 would vest in the amount of 9,123 shares, with options to purchase 11,151 shares being forfeited. On 1/19/10, the Committee determined that options for the period ending 12/31/09 would vest in the amount of 12,500 shares, with options to purchase 12,500 shares being forfeited. On 12/17/10, the Committee determined that options for the period ending 12/31/10 would vest in the amount of 25,000 shares.
On July 7, 2009, the Reporting Person was granted an option to purchase up to 150,000 shares of common stock of the Issuer, 37,500 of which were immediately exercisable. Vesting of 75,000 of the shares subject to the option was based on the achievement of certain performance milestones (or a pro rata portion thereof for a five-month period of such milestones) following the date of grant. On February 15, 2010, the Reporting Person's right to purchase 63,750 shares of such 75,000-share installment vested based on the achievement of such milestones; the remaining 11,250 shares of such installment were forfeited. Vesting of the final 37,500 shares of the total grant was subject to certain other performance milestones (or a pro rata portion thereof). On January 3, 2011, the Reporting Person's right to purchase 27,192 shares of such final 37,500-share installment vested based on the achievement of such milestones; the remaining 10,308 shares of such installment were forfeited.
This option vests in four equal quarterly installments over one year with the first installment vesting on September 30, 2010.
This option vests in four equal quarterly installments over one year with the first installment vesting on August 26, 2011.
The warrants are exercisable for a period of five years beginning on the earlier of (i) the date on which a registration statement under the Securities Act of 1933, as amended, covering the shares of common stock issuable upon exercise of the warrants and the subsequent resale of such shares is declared effective by the Securities and Exchange Commission, and (ii) one year and one day after issuance.